E Fund Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$603K Buy
+9,150
New +$582K 0.02% 246
2025
Q2
$625K Buy
18,919
+5,136
+37% +$179K 0.03% 204
2025
Q1
$554K Buy
13,783
+2,039
+17% +$93.7K 0.03% 213
2024
Q4
$552K Sell
11,744
-1,993
-15% -$104K 0.03% 214
2024
Q3
$725K Sell
13,737
-2,190
-14% -$122K 0.04% 166
2024
Q2
$863K Buy
15,927
+9,336
+142% +$564K 0.05% 137
2024
Q1
$462K Sell
6,591
-7,494
-53% -$580K 0.03% 166
2023
Q4
$1.18M Buy
14,085
+1,404
+11% +$50.8K 0.07% 81
2023
Q3
$374K Buy
12,681
+619
+5% +$20.6K 0.03% 177
2023
Q2
$393K Buy
12,062
+1,214
+11% +$44.9K 0.03% 176
2023
Q1
$382K Sell
10,848
-958
-8% -$39.1K 0.03% 181
2022
Q4
$541K Buy
11,806
+3,068
+35% +$132K 0.05% 123
2022
Q3
$423K Sell
8,738
-2,348
-21% -$113K 0.04% 167
2022
Q2
$436K Buy
11,086
+3,932
+55% +$158K 0.04% 172
2022
Q1
$263K Buy
7,154
+2,350
+49% +$83.5K 0.01% 243
2021
Q4
$219K Sell
4,804
-1,036
-18% -$40K 0.01% 244
2021
Q3
$209K Buy
+5,840
New +$172K 0.01% 227

Other funds holding CYTK